W. Yao

Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors

Guoqing Liu, Zhenping Chen, R. Wu, 2021, Research and practice in thrombosis and haemostasis.

Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study

V. Blanchette, A. Abad, Zhenping Chen, 2021, Research and practice in thrombosis and haemostasis.

The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE Study

J. Gu, G. Feng, Juan Xiao, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes

Guoqing Liu, Zhenping Chen, R. Wu, 2022, Research and practice in thrombosis and haemostasis.

Eradication of FIX inhibitor in haemophilia B children using low‐dose immune tolerance induction with rituximab‐based immunosuppressive agent(s) in China

Guoqing Liu, Zhenping Chen, R. Wu, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Application of peripherally inserted central catheter in immune tolerance induction treatment of children with hemophilia A and accompanying inhibitors in China.

Guoqing Liu, Zekun Li, Y. Zhen, 2023, Hematology.

Central venous access devices implantation in children with severe hemophilia a: data from the children comprehensive care center of China

Guoqing Liu, Zhenping Chen, Y. Zhen, 2023, Heliyon.

The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in China.

Guoqing Liu, Zhenping Chen, Zekun Li, 2023, Thrombosis Research.

The efficacy of sequential MMF-rescue-regimen to eradicate inhibitors for refractory severe hemophilia A inhibitor children in China.

Guoqing Liu, Zhenping Chen, Zekun Li, 2023, Thrombosis Research.

Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors.

Guoqing Liu, Zhenping Chen, Zekun Li, 2023, Thrombosis research.

Nephrotic syndrome in two haemophilia B children with inhibitor under low‐dose immune tolerance induction combined with rituximab‐based immunosuppressant protocol

Guoqing Liu, Zhenping Chen, R. Wu, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.